Table 4. Specific characteristics of patient whit positive hormone receptors.

N.	Age	Gender	Smoke	Stage	Site of metastasis	ER	PgR	n-AR	c-AR
1	61	M	Y	IIIB	Unk	0%	0%	2%	0%
2	60	M	Y	IV	Bone	0%	0%	20%	0%
3	62	M	N	IIIA	Lung	0%	0%	20%	0%
4	70	M	Y	IV	Lung	0%	0%	20%	0%
5	76	M	Y	IIA	CNS	0%	0%	20%	0%
6	78	M	Y	IV	Lung	0%	0%	20%	0%
7	82	M	Y	IIIB	Unk	0%	0%	30%	0%
8	68	M	Y	IIIA	Lymph-node; pleura	0%	0%	0%	20%
9	57	M	Y	IV	CNS; lymph-node	0%	0%	0%	40%
10	66	M	N	IV	Bone	0%	0%	0%	40%
11	74	M	Y	IIB	Lung; pleura	0%	0%	0%	50%
12	74	F	N	IV	Lung; bone	0%	0%	0%	50%
13	50	M	Y	IV	Lung; pleura	0%	0%	0%	60%
14	62	M	Y	IV	Lung	0%	0%	0%	70%
15	71	M	Y	UNK	Unk	0%	0%	0%	80%
16	69	F	Y	IV	Liver	0%	0%	0%	85%
17	58	F	N	IV	Pleura; liver; bone	0%	20%	0%	0%
18	53	F	N	I	Unk	2%	9%	0%	0%
19	74	M	Y	IV	CNS	3%	0%	0%	10%
20	76	F	Y	IIA	Lymph-node	10%	8%	0%	0%
21	70	F	N	IIB	Lung; Lymph-node, bone	15%	12%	0%	0%
22	70	M	Y	IIA	Unk	15%	15%	12%	25%
23	62	F	N	IV	Pleura; lung	60%	0%	0%	0%
24	68	F	N	IB	Lung	85%	85%	50%	0%
25	61	M	Y	IV	Lung	0%	0%	0%	0%